レポートナンバー 0000030173
世界の薬物検査市場：業界分析と予測 - 薬物タイプ別・サンプルタイプ別・製品タイプ別・エンドユーザー別・地域別の展望（2021年〜2027年）
KBV Research
Global Drug Testing Market By Drug Type (Cannabis/Marijuana, Opioids, Cocaine, Alcohol, Amphetamine & Methamphetamine, LSD and Others), By Sample Type (Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples), By Product Type (Consumables, Instruments, Rapid Testing Devices and Services), By End User (Drug Testing Laboratories, Workplaces, Hospitals and Others), By Regional Outlook, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027
発刊日
2021/06/30
言語英語
体裁PDF/301ページ
レポート概要
薬物検査の世界市場規模は、予測期間中に5.1%のCAGRで上昇し、2027年には117億ドルに達すると予想されています。薬物検査とは、サンプル（生体試料）を用いて薬物またはその代謝物の有無を確認するプロセスを指します。この手順は、様々な環境や技術を用いて行うことができます。体内ではさまざまな薬物がさまざまな速度で代謝されるため、一部の薬物や代謝物を特定するための期間は非常に特殊であり、物質によって大きく異なる場合があります。いくつかの制限はありますが、患者の自己申告、臨床検査、副次的な報告では物質使用の実際の発生率を見誤る可能性があるため、薬物検査は臨床現場では非常に重要です。しかし、薬物検査は、心理社会的評価と病歴・身体的評価を伴わなければなりません。
法的事件、執行猶予、離婚、親権、裁判所の命令による検査、従業員の検査など、様々な要因で薬物検査が必要となります。それに加えて、世界や国レベルの様々なスポーツイベントでは、選手がパフォーマンス強化薬を使用したかどうかを知るために薬物検査が必要となります。薬物検査には、検査の目的によって様々な種類があります。髪の毛、尿、血液、唾液、汗などがあります。最も一般的な検査は、簡単で費用対効果が高く、迅速な結果が得られる尿検査である。尿検査は、連邦政府が義務づけている唯一の検査方法です。尿検査は、大部分の薬物について、過去数日間にその物質が使用されたかどうかを特定するのに十分な効率性があります。
薬物乱用の追跡と対策を目的としたいくつかの政府の取り組みが市場を後押ししています。カナダ保健省のSUAP（Substance Use and Addictions Program：物質使用および依存症プログラム）は、カナダにおける薬物乱用問題の削減を目的としたプロジェクトに投資し、貢献しています。このイニシアチブは、カナダ全土での薬物使用の予防、危害の軽減、および治療プログラムに取り組んでいます。2016年4月、ニューヨーク市政府は、薬物乱用の治療を行う医師やカウンセラーを養成し、合成オピオイドの検査を増やすなど、幅広い取り組みを導入しました。国家薬物取締予算（The National Drug Control Budget）は、2020年度に、アメリカの5つの薬物機能的側面（運用、法執行、予防、治療、および禁止）にわたって346億USドルを計上しました。
COVID-19の影響
COVID-19は、世界中のビジネスや経済活動に大きな減速をもたらしており、医療施設や治療センター、ハームリダクションサービスを提供する業者のアクセスが低い、あるいは不可能であることや、感染症の伝播の恐れがあることから、薬物検査市場に短期的な悪影響を及ぼすと考えられます。医療システムへの負担を軽減し、ウイルス感染の可能性を減らすために、世界のいくつかの国の政府は、必要のない医療や外科手術を延期または中止するようなガイドラインを提示しました。
厳しいロックダウンのガイドラインや、旅行、公共の集まり、ビジネス活動、避難命令などが制限されており、これらの点が市場の成長にさらに影響を与えています。世界の様々な国が国を挙げてロックダウンを開始しており、産業の一時的な停止、製造、事業展開、生産などに大きな影響が出ています。貿易障壁は、需要と供給のギャップにさらに悪影響を及ぼしています。薬物検査市場に携わる企業は、世界的なサプライチェーンの乱れ、需要の減少、顧客の事業停止などに直面しています。
薬物タイプの展望
薬剤タイプ別に、大麻/マリファナ、オピオイド、コカイン、アルコール、アンフェタミン/メタンフェタミン、LSD、その他に分類されます。2020年の薬物検査市場では、大麻/マリファナ分野が最も高い収益シェアを獲得しました。これは、大麻が主要な市場で一般的に使用されている違法薬物であることから、検査キットや検査機器の需要が大きいためです。
サンプルタイプ別
サンプルタイプ別に、尿サンプル、口腔液サンプル、毛髪サンプル、その他のサンプルに分類されます。尿検体は、2020年に最大の収益シェアを獲得し、薬物検査市場の支配的なセグメントとなりました。このセグメントは、予測期間中、より速いCAGRを示します。尿サンプルは、違法な物質の存在を確認するために非常に一般的なサンプルタイプであり、この要因がこのセグメントの成長につながっています。しかし、市場の成長は、尿サンプルに不純物が混入することが多くなっており、偽陰性の検査結果がでるという事実によって妨げられるでしょう。
製品タイプの展望
製品タイプに基づいて、市場は消耗品、機器、迅速検査装置、サービスに分けられます。2020年の薬物検査市場では、消耗品分野が最大の収益シェアを獲得しました。この市場の成長を支えているのは、検査の簡便性、正確性、迅速な結果をもたらす高度なソリューションを提供する先進的な消耗品の導入が進んでいることです。
エンドユーザーの展望
エンドユーザー別では、薬物検査ラボ、職場、病院、その他に分類されています。予測期間中、最も速い成長率を示すのは職場です。これは、雇用前の薬物乱用スクリーニングや、薬物のない環境を作るためのランダムな薬物検査の利用が増加しているためです。それに加えて、職場での事故の場合、薬物検査を利用することで、事故が薬物の影響下で起こったかどうかを知ることができ、所有者の損害賠償責任をなくすことができます。組織は薬物検査に37億5,000万米ドル以上を費やしています。
地域の展望
地域別では、北アメリカ、ヨーロッパ、アジア太平洋、中南米、中東・アフリカに分類されています。アジア太平洋地域では、インドや中国などの発展途上国で薬物乱用検査の需要が高まっていることから、薬物検査市場は予測期間中に新たな成長の道を歩むことになるでしょう。これらの国では、薬物乱用障害、致命的な交通事故、薬物関連犯罪などの増加に伴い、薬物検査の需要が高まっています。しかし、職場での薬物検査に関する明確な規制がないため、市場の成長は鈍化しています。
この市場調査レポートは、市場の主要な利害関係者の分析をカバーしています。このレポートで紹介されている主要企業には、Quest Diagnostics, Incorporated社、Abbott Laboratories社、F. Hoffmann-La Roche Ltd.社、Thermo Fisher Scientific, Inc.社、Siemens AG (Siemens Healthineers)社、Agilent Technologies, Inc.社、Bio-Rad Laboratories, Inc.社、Dragerwerk AG & Co. KGaA社、Quidel Corporation社、Omega Laboratories, Inc.社が含まれます。
調査範囲
-
薬物タイプ別
➣ 大麻/マリファナ
➣ オピオイド
➣ コカイン
➣ アルコール
➣ アンフェタミン・メタンフェタミン
➣ LSD
➣ その他
-
サンプルタイプ別
➣ 尿
➣ 口腔液
➣ 毛髪
➣ その他
-
製品タイプ別
➣ 消耗品
➣ 機器
➣ 迅速検査デバイス
➣ サービス
-
エンドユーザー別
➣ 薬物検査ラボ
➣ 職場
➣ 病院
➣ その他
-
地域別
➣ 北アメリカ
◇ アメリカ
◇ カナダ
◇ メキシコ
◇ その他の北アメリカ
➣ ヨーロッパ
◇ ドイツ
◇ イギリス
◇ フランス
◇ ロシア
◇ スペイン
◇ イタリア
◇ その他のヨーロッパ
➣ アジア太平洋地域
◇ 中国
◇ 日本
◇ インド
◇ 韓国
◇ シンガポール
◇ マレーシア
◇ その他のアジア太平洋地域
➣ LAMEA
◇ ブラジル
◇ アルゼンチン
◇ UAE
◇ サウジアラビア
◇ 南アフリカ
◇ ナイジェリア
◇ その他のLAMEA
-
調査企業
➣ Quest Diagnostics, Incorporated
➣ Abbott Laboratories
➣ F. Hoffmann-La Roche Ltd.
➣ Thermo Fisher Scientific, Inc.
➣ Siemens AG (Siemens Healthineers)
➣ Agilent Technologies, Inc.
➣ Bio-Rad Laboratories, Inc.
➣ Dragerwerk AG & Co. KGaA
➣ Quidel Corporation
➣ Omega Laboratories, Inc.
レポート詳細
目次
Table of Contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Drug Testing Market, by Drug Type
1.4.2 Global Drug Testing Market, by Sample Type
1.4.3 Global Drug Testing Market, by Product Type
1.4.4 Global Drug Testing Market, by End User
1.4.5 Global Drug Testing Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Drug Testing Market by Drug Type
3.1 Global Cannabis/Marijuana Drug Testing Market by Region
3.2 Global Opioids Drug Testing Market by Region
3.3 Global Cocaine Drug Testing Market by Region
3.4 Global Alcohol Drug Testing Market by Region
3.5 Global Amphetamine & Methamphetamine Drug Testing Market by Region
3.6 Global LSD Drug Testing Market by Region
3.7 Global Other Drug Type Drug Testing Market by Region
Chapter 4. Global Drug Testing Market by Sample Type
4.1 Global Drug Testing Urine Samples Market by Region
4.2 Global Drug Testing Oral Fluid Samples Market by Region
4.3 Global Drug Testing Hair Samples Market by Region
4.4 Global Drug Testing Other Samples Market by Region
Chapter 5. Global Drug Testing Market by Product Type
5.1 Global Consumables Drug Testing Market by Region
5.2 Global Instruments Drug Testing Market by Region
5.3 Global Rapid Testing Devices Drug Testing Market by Region
5.4 Global Services Drug Testing Market by Region
Chapter 6. Global Drug Testing Market by End-use
6.1 Global Drug Testing Laboratories Drug Testing Market by Region
6.2 Global Workplaces Drug Testing Market by Region
6.3 Global Hospitals Drug Testing Market by Region
6.4 Global Others Drug Testing Market by Region
Chapter 7. Global Drug Testing Market by Region
7.1 North America Drug Testing Market
7.1.1 North America Drug Testing Market by Drug Type
7.1.1.1 North America Cannabis/Marijuana Drug Testing Market by Country
7.1.1.2 North America Opioids Drug Testing Market by Country
7.1.1.3 North America Cocaine Drug Testing Market by Country
7.1.1.4 North America Alcohol Drug Testing Market by Country
7.1.1.5 North America Amphetamine & Methamphetamine Drug Testing Market by Country
7.1.1.6 North America LSD Drug Testing Market by Country
7.1.1.7 North America Other Drug Type Drug Testing Market by Country
7.1.2 North America Drug Testing Market by Sample Type
7.1.2.1 North America Drug Testing Urine Samples Market by Country
7.1.2.2 North America Drug Testing Oral Fluid Samples Market by Country
7.1.2.3 North America Drug Testing Hair Samples Market by Country
7.1.2.4 North America Drug Testing Other Samples Market by Country
7.1.3 North America Drug Testing Market by Product Type
7.1.3.1 North America Consumables Drug Testing Market by Country
7.1.3.2 North America Instruments Drug Testing Market by Country
7.1.3.3 North America Rapid Testing Devices Drug Testing Market by Country
7.1.3.4 North America Services Drug Testing Market by Country
7.1.4 North America Drug Testing Market by End-use
7.1.4.1 North America Drug Testing Laboratories Drug Testing Market by Country
7.1.4.2 North America Workplaces Drug Testing Market by Country
7.1.4.3 North America Hospitals Drug Testing Market by Country
7.1.4.4 North America Others Drug Testing Market by Country
7.1.5 North America Drug Testing Market by Country
7.1.5.1 US Drug Testing Market
7.1.5.1.1 US Drug Testing Market by Drug Type
7.1.5.1.2 US Drug Testing Market by Sample Type
7.1.5.1.3 US Drug Testing Market by Product Type
7.1.5.1.4 US Drug Testing Market by End-use
7.1.5.2 Canada Drug Testing Market
7.1.5.2.1 Canada Drug Testing Market by Drug Type
7.1.5.2.2 Canada Drug Testing Market by Sample Type
7.1.5.2.3 Canada Drug Testing Market by Product Type
7.1.5.2.4 Canada Drug Testing Market by End-use
7.1.5.3 Mexico Drug Testing Market
7.1.5.3.1 Mexico Drug Testing Market by Drug Type
7.1.5.3.2 Mexico Drug Testing Market by Sample Type
7.1.5.3.3 Mexico Drug Testing Market by Product Type
7.1.5.3.4 Mexico Drug Testing Market by End-use
7.1.5.4 Rest of North America Drug Testing Market
7.1.5.4.1 Rest of North America Drug Testing Market by Drug Type
7.1.5.4.2 Rest of North America Drug Testing Market by Sample Type
7.1.5.4.3 Rest of North America Drug Testing Market by Product Type
7.1.5.4.4 Rest of North America Drug Testing Market by End-use
7.2 Europe Drug Testing Market
7.2.1 Europe Drug Testing Market by Drug Type
7.2.1.1 Europe Cannabis/Marijuana Drug Testing Market by Country
7.2.1.2 Europe Opioids Drug Testing Market by Country
7.2.1.3 Europe Cocaine Drug Testing Market by Country
7.2.1.4 Europe Alcohol Drug Testing Market by Country
7.2.1.5 Europe Amphetamine & Methamphetamine Drug Testing Market by Country
7.2.1.6 Europe LSD Drug Testing Market by Country
7.2.1.7 Europe Other Drug Type Drug Testing Market by Country
7.2.2 Europe Drug Testing Market by Sample Type
7.2.2.1 Europe Drug Testing Urine Samples Market by Country
7.2.2.2 Europe Drug Testing Oral Fluid Samples Market by Country
7.2.2.3 Europe Drug Testing Hair Samples Market by Country
7.2.2.4 Europe Drug Testing Other Samples Market by Country
7.2.3 Europe Drug Testing Market by Product Type
7.2.3.1 Europe Consumables Drug Testing Market by Country
7.2.3.2 Europe Instruments Drug Testing Market by Country
7.2.3.3 Europe Rapid Testing Devices Drug Testing Market by Country
7.2.3.4 Europe Services Drug Testing Market by Country
7.2.4 Europe Drug Testing Market by End-use
7.2.4.1 Europe Drug Testing Laboratories Drug Testing Market by Country
7.2.4.2 Europe Workplaces Drug Testing Market by Country
7.2.4.3 Europe Hospitals Drug Testing Market by Country
7.2.4.4 Europe Others Drug Testing Market by Country
7.2.5 Europe Drug Testing Market by Country
7.2.5.1 Germany Drug Testing Market
7.2.5.1.1 Germany Drug Testing Market by Drug Type
7.2.5.1.2 Germany Drug Testing Market by Sample Type
7.2.5.1.3 Germany Drug Testing Market by Product Type
7.2.5.1.4 Germany Drug Testing Market by End-use
7.2.5.2 UK Drug Testing Market
7.2.5.2.1 UK Drug Testing Market by Drug Type
7.2.5.2.2 UK Drug Testing Market by Sample Type
7.2.5.2.3 UK Drug Testing Market by Product Type
7.2.5.2.4 UK Drug Testing Market by End-use
7.2.5.3 France Drug Testing Market
7.2.5.3.1 France Drug Testing Market by Drug Type
7.2.5.3.2 France Drug Testing Market by Sample Type
7.2.5.3.3 France Drug Testing Market by Product Type
7.2.5.3.4 France Drug Testing Market by End-use
7.2.5.4 Russia Drug Testing Market
7.2.5.4.1 Russia Drug Testing Market by Drug Type
7.2.5.4.2 Russia Drug Testing Market by Sample Type
7.2.5.4.3 Russia Drug Testing Market by Product Type
7.2.5.4.4 Russia Drug Testing Market by End-use
7.2.5.5 Spain Drug Testing Market
7.2.5.5.1 Spain Drug Testing Market by Drug Type
7.2.5.5.2 Spain Drug Testing Market by Sample Type
7.2.5.5.3 Spain Drug Testing Market by Product Type
7.2.5.5.4 Spain Drug Testing Market by End-use
7.2.5.6 Italy Drug Testing Market
7.2.5.6.1 Italy Drug Testing Market by Drug Type
7.2.5.6.2 Italy Drug Testing Market by Sample Type
7.2.5.6.3 Italy Drug Testing Market by Product Type
7.2.5.6.4 Italy Drug Testing Market by End-use
7.2.5.7 Rest of Europe Drug Testing Market
7.2.5.7.1 Rest of Europe Drug Testing Market by Drug Type
7.2.5.7.2 Rest of Europe Drug Testing Market by Sample Type
7.2.5.7.3 Rest of Europe Drug Testing Market by Product Type
7.2.5.7.4 Rest of Europe Drug Testing Market by End-use
7.3 Asia Pacific Drug Testing Market
7.3.1 Asia Pacific Drug Testing Market by Drug Type
7.3.1.1 Asia Pacific Cannabis/Marijuana Drug Testing Market by Country
7.3.1.2 Asia Pacific Opioids Drug Testing Market by Country
7.3.1.3 Asia Pacific Cocaine Drug Testing Market by Country
7.3.1.4 Asia Pacific Alcohol Drug Testing Market by Country
7.3.1.5 Asia Pacific Amphetamine & Methamphetamine Drug Testing Market by Country
7.3.1.6 Asia Pacific LSD Drug Testing Market by Country
7.3.1.7 Asia Pacific Other Drug Type Drug Testing Market by Country
7.3.2 Asia Pacific Drug Testing Market by Sample Type
7.3.2.1 Asia Pacific Drug Testing Urine Samples Market by Country
7.3.2.2 Asia Pacific Drug Testing Oral Fluid Samples Market by Country
7.3.2.3 Asia Pacific Drug Testing Hair Samples Market by Country
7.3.2.4 Asia Pacific Drug Testing Other Samples Market by Country
7.3.3 Asia Pacific Drug Testing Market by Product Type
7.3.3.1 Asia Pacific Consumables Drug Testing Market by Country
7.3.3.2 Asia Pacific Instruments Drug Testing Market by Country
7.3.3.3 Asia Pacific Rapid Testing Devices Drug Testing Market by Country
7.3.3.4 Asia Pacific Services Drug Testing Market by Country
7.3.4 Asia Pacific Drug Testing Market by End-use
7.3.4.1 Asia Pacific Drug Testing Laboratories Drug Testing Market by Country
7.3.4.2 Asia Pacific Workplaces Drug Testing Market by Country
7.3.4.3 Asia Pacific Hospitals Drug Testing Market by Country
7.3.4.4 Asia Pacific Others Drug Testing Market by Country
7.3.5 Asia Pacific Drug Testing Market by Country
7.3.5.1 China Drug Testing Market
7.3.5.1.1 China Drug Testing Market by Drug Type
7.3.5.1.2 China Drug Testing Market by Sample Type
7.3.5.1.3 China Drug Testing Market by Product Type
7.3.5.1.4 China Drug Testing Market by End-use
7.3.5.2 Japan Drug Testing Market
7.3.5.2.1 Japan Drug Testing Market by Drug Type
7.3.5.2.2 Japan Drug Testing Market by Sample Type
7.3.5.2.3 Japan Drug Testing Market by Product Type
7.3.5.2.4 Japan Drug Testing Market by End-use
7.3.5.3 India Drug Testing Market
7.3.5.3.1 India Drug Testing Market by Drug Type
7.3.5.3.2 India Drug Testing Market by Sample Type
7.3.5.3.3 India Drug Testing Market by Product Type
7.3.5.3.4 India Drug Testing Market by End-use
7.3.5.4 South Korea Drug Testing Market
7.3.5.4.1 South Korea Drug Testing Market by Drug Type
7.3.5.4.2 South Korea Drug Testing Market by Sample Type
7.3.5.4.3 South Korea Drug Testing Market by Product Type
7.3.5.4.4 South Korea Drug Testing Market by End-use
7.3.5.5 Singapore Drug Testing Market
7.3.5.5.1 Singapore Drug Testing Market by Drug Type
7.3.5.5.2 Singapore Drug Testing Market by Sample Type
7.3.5.5.3 Singapore Drug Testing Market by Product Type
7.3.5.5.4 Singapore Drug Testing Market by End-use
7.3.5.6 Malaysia Drug Testing Market
7.3.5.6.1 Malaysia Drug Testing Market by Drug Type
7.3.5.6.2 Malaysia Drug Testing Market by Sample Type
7.3.5.6.3 Malaysia Drug Testing Market by Product Type
7.3.5.6.4 Malaysia Drug Testing Market by End-use
7.3.5.7 Rest of Asia Pacific Drug Testing Market
7.3.5.7.1 Rest of Asia Pacific Drug Testing Market by Drug Type
7.3.5.7.2 Rest of Asia Pacific Drug Testing Market by Sample Type
7.3.5.7.3 Rest of Asia Pacific Drug Testing Market by Product Type
7.3.5.7.4 Rest of Asia Pacific Drug Testing Market by End-use
7.4 LAMEA Drug Testing Market
7.4.1 LAMEA Drug Testing Market by Drug Type
7.4.1.1 LAMEA Cannabis/Marijuana Drug Testing Market by Country
7.4.1.2 LAMEA Opioids Drug Testing Market by Country
7.4.1.3 LAMEA Cocaine Drug Testing Market by Country
7.4.1.4 LAMEA Alcohol Drug Testing Market by Country
7.4.1.5 LAMEA Amphetamine & Methamphetamine Drug Testing Market by Country
7.4.1.6 LAMEA LSD Drug Testing Market by Country
7.4.1.7 LAMEA Other Drug Type Drug Testing Market by Country
7.4.2 LAMEA Drug Testing Market by Sample Type
7.4.2.1 LAMEA Drug Testing Urine Samples Market by Country
7.4.2.2 LAMEA Drug Testing Oral Fluid Samples Market by Country
7.4.2.3 LAMEA Drug Testing Hair Samples Market by Country
7.4.2.4 LAMEA Drug Testing Other Samples Market by Country
7.4.3 LAMEA Drug Testing Market by Product Type
7.4.3.1 LAMEA Consumables Drug Testing Market by Country
7.4.3.2 LAMEA Instruments Drug Testing Market by Country
7.4.3.3 LAMEA Rapid Testing Devices Drug Testing Market by Country
7.4.3.4 LAMEA Services Drug Testing Market by Country
7.4.4 LAMEA Drug Testing Market by End-use
7.4.4.1 LAMEA Drug Testing Laboratories Drug Testing Market by Country
7.4.4.2 LAMEA Workplaces Drug Testing Market by Country
7.4.4.3 LAMEA Hospitals Drug Testing Market by Country
7.4.4.4 LAMEA Others Drug Testing Market by Country
7.4.5 LAMEA Drug Testing Market by Country
7.4.5.1 Brazil Drug Testing Market
7.4.5.1.1 Brazil Drug Testing Market by Drug Type
7.4.5.1.2 Brazil Drug Testing Market by Sample Type
7.4.5.1.3 Brazil Drug Testing Market by Product Type
7.4.5.1.4 Brazil Drug Testing Market by End-use
7.4.5.2 Argentina Drug Testing Market
7.4.5.2.1 Argentina Drug Testing Market by Drug Type
7.4.5.2.2 Argentina Drug Testing Market by Sample Type
7.4.5.2.3 Argentina Drug Testing Market by Product Type
7.4.5.2.4 Argentina Drug Testing Market by End-use
7.4.5.3 UAE Drug Testing Market
7.4.5.3.1 UAE Drug Testing Market by Drug Type
7.4.5.3.2 UAE Drug Testing Market by Sample Type
7.4.5.3.3 UAE Drug Testing Market by Product Type
7.4.5.3.4 UAE Drug Testing Market by End-use
7.4.5.4 Saudi Arabia Drug Testing Market
7.4.5.4.1 Saudi Arabia Drug Testing Market by Drug Type
7.4.5.4.2 Saudi Arabia Drug Testing Market by Sample Type
7.4.5.4.3 Saudi Arabia Drug Testing Market by Product Type
7.4.5.4.4 Saudi Arabia Drug Testing Market by End-use
7.4.5.5 South Africa Drug Testing Market
7.4.5.5.1 South Africa Drug Testing Market by Drug Type
7.4.5.5.2 South Africa Drug Testing Market by Sample Type
7.4.5.5.3 South Africa Drug Testing Market by Product Type
7.4.5.5.4 South Africa Drug Testing Market by End-use
7.4.5.6 Nigeria Drug Testing Market
7.4.5.6.1 Nigeria Drug Testing Market by Drug Type
7.4.5.6.2 Nigeria Drug Testing Market by Sample Type
7.4.5.6.3 Nigeria Drug Testing Market by Product Type
7.4.5.6.4 Nigeria Drug Testing Market by End-use
7.4.5.7 Rest of LAMEA Drug Testing Market
7.4.5.7.1 Rest of LAMEA Drug Testing Market by Drug Type
7.4.5.7.2 Rest of LAMEA Drug Testing Market by Sample Type
7.4.5.7.3 Rest of LAMEA Drug Testing Market by Product Type
7.4.5.7.4 Rest of LAMEA Drug Testing Market by End-use
Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 F. Hoffmann-La Roche Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Siemens AG (Siemens Healthineers)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Agilent Technologies, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Dragerwerk AG & Co. KGaA
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Quidel Corporation
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Trials & Approvals:
8.10. Omega Laboratories, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
8.10.2.2 Accreditation:
